Abbott’s Freestyle Libre 2 iCGM Receives FDA Clearance For Adults And Children With Diabetes In The U.S.

Abbott Freestyle Libre 2 FDA Clearance
Image: PRNewswire
Abbott, the worldwide leader in continuous glucose monitoring (CGM), received FDA clearance for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children ages 4 and […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleNeopenda Wearable Neonatal Vital Signs Monitor To Be Used For COVID-19 Patients
Next articleThis Wearable Patch May Provide Painless, More Effective Chemotherapy For Melanoma
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.